Arne Scheu
Co-Founder & CEO at Valink Therapeutics | making better ADCs | DPhil | Rhodes Scholar
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
Experience
Career
2025Valink Therapeutics
Co-founderCo-Founder & CEO · Cambridge, Massachusetts, United States · 2025 – Present
2020Valink Therapeutics
Co-founderCo-Founder & CEO · Greater London · 2020 – 2025
2017University of Oxford
DPhil Biochemistry · Oxford, United Kingdom · 2017 – 2021
2016KAUST (King Abdullah University of Science and Technology)
Master Thesis Student · Thuwal · 2016 – 2017
2015CNRS
Visiting Student · Illkirch-Graffenstaden, Grand Est, France · 2015
2014University of Konstanz
Student Research Assistant · Constance, Baden-Württemberg, Germany · 2014
2013University of Konstanz
Student Research Assistant · Constance, Baden-Württemberg, Germany · 2013 – 2014
2013SAP
Working Student · Walldorf, Baden-Württemberg, Germany · 2013
2012SAP
Temporary Worker · Walldorf, Baden-Württemberg, Germany · 2012
Bio
Rhodes Scholar & DPhil Biochemistry from the University of Oxford